文献速递生殖医学

子宫内膜积液对单整倍体冻胚移植的影响:是否取消周期?

The impact of endometrial fluid on single euploid frozen embryo transfers, to cancel or not?
PubMed 文献 · Hum Reprod · 2026-01-01

积液持续组活产率较无积液组显著降低20.2个百分点,但取消周期后的后续移植活产率与积液持续组移植无显著差异,提示取消周期未必改善活产机会。

要点

  • 积液持续至孕酮启动/触发决策日时,单整倍体冻胚移植活产率显著降低20.2个百分点。
  • 积液消退组活产率降低9.4个百分点,但未达统计学显著性。
  • 因积液取消周期后,后续移植活产率与积液持续组移植无显著差异,取消未必获益。

核心结论

  • 积液持续至孕酮启动/触发决策日时单整倍体冻胚移植活产率显著降低20.2个百分点。
  • 尽管活产率降低,因积液取消周期可能并未提高后续活产机会。

主要发现

  • 积液消退组活产率49.1% vs 无积液组58.5%,aOR 0.71(95%CI 0.47,1.05),差异未达显著。
  • 积液持续组活产率38.3% vs 无积液组58.5%,aOR 0.50(95%CI 0.28,0.88),显著降低20.2个百分点。
  • 90个因积液取消的周期中,58个后续完成移植,其中23例积液复发但未取消,总体活产率39.7%,与积液持续组无显著差异(aOR 0.99,95%CI 0.38,2.64)。

关键数值与推荐

  • 积液持续组与无积液组活产率比较aOR 0.50(95%CI 0.28,0.88)。
  • 积液消退组与无积液组活产率比较aOR 0.71(95%CI 0.47,1.05)。
  • 后续移植周期与积液持续组活产率比较aOR 0.99(95%CI 0.38,2.64)。

临床怎么用

  • 积液持续至孕酮启动决策日时,应告知患者活产率显著降低。
  • 因积液取消周期未必改善活产机会,决策需个体化。
  • 积液常提示潜在子宫内膜病变,应进行相应评估。

局限性

  • 回顾性单中心设计可能限制普适性。
  • 仅分析整倍体胚胎引入选择偏倚。
  • 积液病因不明且记录不统一,积液组样本量小。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: What is the impact of endometrial fluid (EF) on single, euploid frozen embryo transfer (FET) cycles on live birth rate (LBR) and is cycle cancellation for EF a worthwhile intervention? SUMMARY ANSWER: The LBR of single euploid FETs was significantly lower by 20.2 percentage points when EF was persistent on the day of decision for progesterone start/trigger, but despite the lower LBR, cycle cancellation may not confer an improved chance at live birth. WHAT IS KNOWN ALREADY: The incidence of EF in cycles ranges from 3% to 8%, thus, only a few small studies have been performed to evaluate its impact. Existing literature generally concludes that the presence of EF leading up to an embryo transfer is detrimental to successful implantation, however, these studies examined untested embryos. STUDY DESIGN, SIZE, DURATION: A retrospective cohort study was performed at a single, academically affiliated infertility center in the USA from January 2014 to December 2022. Inclusion criteria comprised patients who underwent their first IVF cycle, had pre-implantation genetic testing for aneuploidy performed by trophectoderm biopsy, had at least one euploid embryo, and were undergoing their first FET. Cycles were subdivided into three groups: no EF present in the cycle (no EF group), EF present but resolved prior to the day of decision for progesterone start/trigger (EF resolved group), and lastly, EF persistent on the day of decision for progesterone start/trigger (EF persistent group). Clinical outcomes were compared between the groups. In a secondary analysis, all single, euploid FET cycles that were cancelled due to EF were identified. The first subsequent completed single, euploid FET during the same study period was identified and analyzed. PARTICIPANTS/MATERIALS, SETTING, METHODS: Four thousand three hundred eight FET cycles met inclusion criteria. Four thousand one hundred forty documented no EF, 108 documented EF that resolved, and 60 documented EF that persisted. The primary outcome was LBR per ET. A logistic regression analysis was performed adjusting for baseline characteristics (age, BMI, gravidity, parity, reason for infertility) and cycle characteristics (method of fertilization, protocol, endometrial thickness achieved during FET, embryo grade/day cryopreserved). In our secondary analysis, 90 single, euploid FET cycles were identified as cancelled specifically due to the presence of EF. Following these 90 cancelled cycles, there were 58 cycles that were identified as the first subsequent completed FET after cancellation. For the first subsequent completed single, euploid FET after index cycle cancellation, the presence of EF and overall LBR were recorded. MAIN RESULTS AND THE ROLE OF CHANCE: When EF was present, but resolved prior to decision for progesterone start/trigger, the LBR was 9.4 percentage points lower compared to the no EF group, however, this did not reach statistical significance (49.1% vs 58.5%, aOR 0.71 (95% CI 0.47, 1.05)). When EF was persistent on ultrasound on day of decision for progesterone start/trigger, the LBR was significantly lower by 20.2 percentage points when compared to the no EF group (38.3% vs 58.5%, aOR 0.50 (95% CI 0.28, 0.88)). Of 58 subsequent FET cycles identified after initial FET cancellation, 23 demonstrated EF recurrence (but were not cancelled). The overall LBR for all 58 subsequent cycles was 39.7% which was not significantly different from the EF persistent group (aOR 0.99 (95% CI 0.38, 2.64)). LIMITATIONS, REASONS FOR CAUTION: The retrospective, single center design may limit generalizability. Analysis of only euploid embryos introduces selection bias. Challenges of studying EF include the variable and unknown etiology of EF and non-uniform documentation of quantity/measurement of EF. Given the low incidence of EF, the sample sizes are small in the EF groups but are similar in size to previous studies. Power analysis was conducted and to achieve an 80% chance of finding a 10% difference in LBR, 385 patients would be needed in each group. In light of the actual LBR difference of 20.2 percentage points (58.5% vs 38.3%), our sample size of 60 patients in the EF group provided an 88% chance of finding a statistically significant difference. WIDER IMPLICATIONS OF THE FINDINGS: The LBR was 9.4 percentage points lower when EF resolved and 20.2 percentage points lower when EF was persistent. We identified a small cohort of subsequent cycles after initial cycle cancellation and the LBR achieved in these cycles was similar to the LBR in the index transfer cycle if the transfer was performed even in the setting of persistent EF at time of progesterone start/trigger; perhaps if EF is persistent, cycle cancellation may not confer an improved LBR. Overall, many cases of EF likely result from underlying endometrial pathology. Patients should be counseled accordingly. STUDY FUNDING/COMPETING INTEREST(S): No funding was used for this study. The authors have no conflicts of interest. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Patel K, Sakkas D, Morse B, et al. The impact of endometrial fluid on single euploid frozen embryo transfers, to cancel or not? Hum Reprod. 2026. PMID: 41639890. doi:10.1093/humrep/deag010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。